On the other hand, FGFR4 has been proposed as a novel RTK target for HCC based on studies where FGF19-mediated FGFR4 activation resulted in hepatocyte proliferation and HCC formation [11,28]. Here, FGFR4 is linked to hepatocellular carcinoma.